Novartis Venture Fund Overview
The Novartis Venture Fund (NVF) is a corporate venture capital firm managing over USD 750 million in committed capital, investing in more than 40 life science companies across North America and Europe. NVF focuses on biotechnology and biopharmaceutical companies at various stages of growth and development, aiming to foster innovation and address unmet patient needs.
Is Novartis Venture Fund the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Novartis Venture Fund, along with a list of other relevant VCs, is available on Hopohopo.io.
Novartis Venture Fund
Investment focus
Product type
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- PharmaTech
Investment role
Lead and follow
Stages
Seed, Series A
First ticket size
US$5,000,000 - US$25,000,000
Contact information
Global Head of NVF
Anja Koenig
Analyst
Elena Battistello
Principal
Mathias Frederiksen
How to approach funds like Novartis Venture Fund
When approaching Novartis Venture Fund (NVF), emphasize how your company's novel therapeutics or platforms address significant unmet patient needs. Highlight your team's expertise and the scientific rigor underpinning your technology, as NVF values strong management and proprietary science. Demonstrating capital efficiency and a clear path to clinical impact will align with NVF's investment strategy.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
